• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于前列腺癌苏木精和伊红图像计算的筛状区指数与根治性前列腺切除术后生化复发相关,并且在 Gleason 分级组 2 中最具预后价值。

Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.

机构信息

Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA.

Public Health Agency of Catalonia, Lleida, Catalonia, Spain.

出版信息

Eur Urol Focus. 2021 Jul;7(4):722-732. doi: 10.1016/j.euf.2021.04.016. Epub 2021 Apr 30.

DOI:10.1016/j.euf.2021.04.016
PMID:33941504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8419103/
Abstract

BACKGROUND

The presence of invasive cribriform adenocarcinoma (ICC), an expanse of cells containing punched-out lumina uninterrupted by stroma, in radical prostatectomy (RP) specimens has been associated with biochemical recurrence (BCR). However, ICC identification has only moderate inter-reviewer agreement.

OBJECTIVE

To investigate quantitative machine-based assessment of the extent and prognostic utility of ICC, especially within individual Gleason grade groups.

DESIGN, SETTING, AND PARTICIPANTS: A machine learning approach was developed for ICC segmentation using 70 RP patients and validated in a cohort of 749 patients from four sites whose median year of surgery was 2007 and with median follow-up of 28 mo. ICC was segmented on one representative hematoxylin and eosin RP slide per patient and the fraction of tumor area composed of ICC, the cribriform area index (CAI), was measured.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

The association between CAI and BCR was measured in terms of the concordance index (c index) and hazard ratio (HR).

RESULTS AND LIMITATIONS

CAI was correlated with BCR (c index 0.62) in the validation set of 411 patients with ICC morphology, especially those with Gleason grade group 2 cancer (n = 192; c index 0.66), and was less prognostic when patients without ICC were included (c index 0.54). A doubling of CAI in the group with ICC morphology was prognostic after controlling for Gleason grade, surgical margin positivity, preoperative prostate-specific antigen level, pathological T stage, and age (HR 1.19, 95% confidence interval 1.03-1.38; p = 0.018).

CONCLUSIONS

Automated image analysis and machine learning could provide an objective, quantitative, reproducible, and high-throughput method of quantifying ICC area. The performance of CAI for grade group 2 cancer suggests that for patients with little Gleason 4 pattern, the ICC fraction has a strong prognostic role.

PATIENT SUMMARY

Machine-based measurement of a specific cell pattern (cribriform; sieve-like, with lots of spaces) in images of prostate specimens could improve risk stratification for patients with prostate cancer. In the future, this could help in expanding the criteria for active surveillance.

摘要

背景

在根治性前列腺切除术(RP)标本中,存在广泛的细胞浸润性筛状腺癌(ICC),其特征为细胞呈打孔状排列,其间无基质分隔,与生化复发(BCR)相关。然而,ICC 的识别仅具有中等的复查者间一致性。

目的

研究 ICC 的定量机器评估方法及其在个别 Gleason 分级组中的预后价值,尤其是 ICC 的程度和预后价值。

设计、设置和参与者:使用 70 例 RP 患者开发了一种用于 ICC 分割的机器学习方法,并在来自四个地点的 749 例患者的队列中进行了验证,这些患者的中位手术年份为 2007 年,中位随访时间为 28 个月。每位患者均从一张代表性的前列腺组织石蜡切片上分割 ICC,并测量肿瘤区域中由 ICC 组成的部分(筛状区域指数,CAI)。

测量结果和统计学分析

使用一致性指数(c 指数)和风险比(HR)来衡量 CAI 与 BCR 之间的相关性。

结果和局限性

CAI 与验证队列中 411 例具有 ICC 形态的患者的 BCR 相关(c 指数 0.62),尤其是 Gleason 分级组 2 癌症患者(n = 192;c 指数 0.66),而当包含没有 ICC 的患者时,CAI 的预后作用较小(c 指数 0.54)。在控制 Gleason 分级、手术切缘阳性、术前前列腺特异性抗原水平、病理 T 分期和年龄后,ICC 形态组中 CAI 的翻倍与预后相关(HR 1.19,95%置信区间 1.03-1.38;p = 0.018)。

结论

自动化图像分析和机器学习可以为定量 ICC 区域提供客观、定量、可重复和高通量的方法。CAI 对 2 级癌症的表现表明,对于 Gleason 4 模式较少的患者,ICC 分数具有很强的预后作用。

患者总结

基于图像的前列腺标本中特定细胞模式(筛状,有很多空间)的机器测量可能会改善前列腺癌患者的风险分层。在未来,这可能有助于扩大主动监测的标准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/e0f72e7455a6/nihms-1696840-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/07bce0c78088/nihms-1696840-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/b99f6b23d968/nihms-1696840-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/aa596bbc01dc/nihms-1696840-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/e0f72e7455a6/nihms-1696840-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/07bce0c78088/nihms-1696840-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/b99f6b23d968/nihms-1696840-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/aa596bbc01dc/nihms-1696840-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e677/8419103/e0f72e7455a6/nihms-1696840-f0004.jpg

相似文献

1
Computationally Derived Cribriform Area Index from Prostate Cancer Hematoxylin and Eosin Images Is Associated with Biochemical Recurrence Following Radical Prostatectomy and Is Most Prognostic in Gleason Grade Group 2.基于前列腺癌苏木精和伊红图像计算的筛状区指数与根治性前列腺切除术后生化复发相关,并且在 Gleason 分级组 2 中最具预后价值。
Eur Urol Focus. 2021 Jul;7(4):722-732. doi: 10.1016/j.euf.2021.04.016. Epub 2021 Apr 30.
2
Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.基于 MRI 的分期与病理分期预测前列腺癌根治术后生化复发的比较。
AJR Am J Roentgenol. 2023 Dec;221(6):773-787. doi: 10.2214/AJR.23.29609. Epub 2023 Jul 5.
3
[Correlation between pathological features at the positive margin and biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer].局限期前列腺癌患者根治性前列腺切除术后切缘阳性的病理特征与生化复发的相关性
Zhonghua Nan Ke Xue. 2025 Mar;31(3):202-207.
4
Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee.Gleason评分对手术切缘阳性的pT3aN0/Nx前列腺癌患者生化复发的影响:来自前列腺癌研究委员会的一项多中心研究
J Cancer Res Clin Oncol. 2017 Nov;143(11):2393-2400. doi: 10.1007/s00432-017-2502-7. Epub 2017 Aug 19.
5
PSMA-PET-derived distance features as biomarkers for predicting outcomes in primary prostate cancer post-radical prostatectomy.基于前列腺特异性膜抗原正电子发射断层扫描(PSMA-PET)得出的距离特征作为预测前列腺癌根治术后原发性前列腺癌预后的生物标志物。
Cancer Imaging. 2025 Jul 22;25(1):93. doi: 10.1186/s40644-025-00907-8.
6
Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis.前列腺癌患者筛状组织学模式的肿瘤学结局:系统评价和荟萃分析。
Prostate Cancer Prostatic Dis. 2023 Dec;26(4):646-654. doi: 10.1038/s41391-022-00600-y. Epub 2022 Oct 10.
7
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.局限性和局部晚期前列腺癌的新辅助和辅助激素治疗
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2.
8
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.前列腺癌的Gleason分级系统是否应进行修改以纳入高级别三级成分?一项系统评价和荟萃分析。
Lancet Oncol. 2007 May;8(5):411-9. doi: 10.1016/S1470-2045(07)70136-5.
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer.验证一种 10 基因分子特征预测局限性前列腺癌生化复发和临床转移的能力。
J Cancer Res Clin Oncol. 2018 May;144(5):883-891. doi: 10.1007/s00432-018-2615-7. Epub 2018 Mar 6.

引用本文的文献

1
Development of a deep learning system for predicting biochemical recurrence in prostate cancer.用于预测前列腺癌生化复发的深度学习系统的开发。
BMC Cancer. 2025 Feb 10;25(1):232. doi: 10.1186/s12885-025-13628-9.
2
Predicting Biochemical Recurrence of Prostate Cancer Post-Prostatectomy Using Artificial Intelligence: A Systematic Review.使用人工智能预测前列腺切除术后前列腺癌的生化复发:一项系统综述。
Cancers (Basel). 2024 Oct 25;16(21):3596. doi: 10.3390/cancers16213596.
3
Undetected Cribriform and Intraductal Prostate Cancer at biopsy is associated with adverse outcomes.

本文引用的文献

1
Computer extracted gland features from H&E predicts prostate cancer recurrence comparably to a genomic companion diagnostic test: a large multi-site study.计算机从苏木精和伊红染色切片中提取的腺体特征预测前列腺癌复发的能力与基因组伴随诊断测试相当:一项大型多中心研究。
NPJ Precis Oncol. 2021 May 3;5(1):35. doi: 10.1038/s41698-021-00174-3.
2
An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study.一种用于经皮穿刺活检全切片图像中前列腺癌诊断的人工智能算法:一项盲法临床验证与应用研究。
Lancet Digit Health. 2020 Aug;2(8):e407-e416. doi: 10.1016/S2589-7500(20)30159-X.
3
活检时未检测到的筛状和导管内前列腺癌与不良预后相关。
Prostate Cancer Prostatic Dis. 2025 Mar;28(1):187-192. doi: 10.1038/s41391-024-00910-3. Epub 2024 Oct 21.
4
Characterization of arteriosclerosis based on computer-aided measurements of intra-arterial thickness.基于动脉内厚度计算机辅助测量的动脉硬化特征分析
J Med Imaging (Bellingham). 2024 Sep;11(5):057501. doi: 10.1117/1.JMI.11.5.057501. Epub 2024 Oct 10.
5
A selective CutMix approach improves generalizability of deep learning-based grading and risk assessment of prostate cancer.一种选择性CutMix方法提高了基于深度学习的前列腺癌分级和风险评估的泛化能力。
J Pathol Inform. 2024 May 7;15:100381. doi: 10.1016/j.jpi.2024.100381. eCollection 2024 Dec.
6
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.前列腺腺癌中,预测转移风险的不良病理学(不利组织学)的优化定义建议,与分级分组和病理分期无关。
Histopathology. 2024 Oct;85(4):598-613. doi: 10.1111/his.15231. Epub 2024 Jun 3.
7
Development and Validation of a Multimodality Model Based on Whole-Slide Imaging and Biparametric MRI for Predicting Postoperative Biochemical Recurrence in Prostate Cancer.基于全切片成像和双参数 MRI 的多模态模型的开发和验证,用于预测前列腺癌术后生化复发。
Radiol Imaging Cancer. 2024 May;6(3):e230143. doi: 10.1148/rycan.230143.
8
Harnessing artificial intelligence for prostate cancer management.利用人工智能进行前列腺癌管理。
Cell Rep Med. 2024 Apr 16;5(4):101506. doi: 10.1016/j.xcrm.2024.101506. Epub 2024 Apr 8.
9
Distinct Adverse Clinical Outcomes of Small and Large Cribriform Patterns on Gleason 7 Prostate Cancer: A Preliminary Study.Gleason 评分 7 分的前列腺癌中小筛状模式和大筛状模式不同的不良临床结局:一项初步研究
Urol Res Pract. 2023 Sep;49(5):324-328. doi: 10.5152/tud.2023.23076.
10
Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review.应用于前列腺癌数字病理学的深度学习方法:系统综述
Diagnostics (Basel). 2023 Aug 14;13(16):2676. doi: 10.3390/diagnostics13162676.
The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
2019 年泌尿生殖系统病理学学会(GUPS)关于当代前列腺癌分级的白皮书。
Arch Pathol Lab Med. 2021 Apr 1;145(4):461-493. doi: 10.5858/arpa.2020-0015-RA.
4
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.2019 年国际泌尿病理学会(ISUP)前列腺癌分级共识会议。
Am J Surg Pathol. 2020 Aug;44(8):e87-e99. doi: 10.1097/PAS.0000000000001497.
5
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study.人工智能在前列腺癌活检中的诊断和分级:一项基于人群的诊断研究。
Lancet Oncol. 2020 Feb;21(2):222-232. doi: 10.1016/S1470-2045(19)30738-7. Epub 2020 Jan 8.
6
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study.利用活检进行前列腺癌 Gleason 分级的自动化深度学习系统:一项诊断研究。
Lancet Oncol. 2020 Feb;21(2):233-241. doi: 10.1016/S1470-2045(19)30739-9. Epub 2020 Jan 8.
7
Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology.人工智能在数字病理学中的应用——诊断和精准肿瘤学的新工具。
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715. doi: 10.1038/s41571-019-0252-y. Epub 2019 Aug 9.
8
Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer.一种用于改善前列腺癌Gleason评分的深度学习算法的开发与验证
NPJ Digit Med. 2019 Jun 7;2:48. doi: 10.1038/s41746-019-0112-2. eCollection 2019.
9
Grading of prostate cancer: a work in progress.前列腺癌分级:一项正在进行中的工作。
Histopathology. 2019 Jan;74(1):146-160. doi: 10.1111/his.13767.
10
Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202.局部晚期前列腺癌中生化失败时间间隔作为替代终点:NRG/RTOG 9202 随机试验分析。
J Clin Oncol. 2019 Jan 20;37(3):213-221. doi: 10.1200/JCO.18.00154. Epub 2018 Dec 7.